GranuFlo and NaturaLyte Recall FAQ
How are GranuFlo and NaturaLyte used in dialysis treatment?
GranuFlo and NaturaLyte are acid concentrates manufactured by Fresenius Medical Care (FMC) that are diluted to become components of dialysate. Dialysate is used during hemodialysis treatment to neutralize acid buildup in the blood.
What is the difference between GranuFlo and NaturaLyte?
GranuFlo and NaturaLyte are both dialysate solutions used during hemodialysis treatment. GranuFlo is a dry acid, while NaturaLyte is a liquid formulation.
Why did the FDA recall GranuFlo and NaturaLyte products?
In March 2012, the Food and Drug Administration (FDA) issued a recall of GranuFlo and NaturaLyte products based on a leaked internal memo from the manufacturers Fresenius Medical Care (FMC). The FMC memo included evidence that high bicarbonate levels in GranuFlo and NaturaLyte products caused dialysis patients with elevated pre-dialysis bicarbonate levels to experience metabolic alkalosis. Metabolic alkalosis can lead to heart attack, stroke and sudden death. Fresenius Medical Care did not issue the same warning to the thousands of dialysis clinics not owned by FMC.
What are the side effects caused by GranuFlo and NaturaLyte?
Am I eligible to file a GranuFlo or NaturaLyte lawsuit?
If you or a loved one experienced heart attack, stroke, or other side effects from hemodialysis treatment with GranuFlo or NaturaLyte, contact the attorneys at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.